560 Eccles Avenue is a trophy-quality, single-tenant industrial/flex-research facility leased by the United States Government through May 2039. The lease is backed by an AA+ credit rating from Standard & Poor’s. Serving as a mission-critical USDA–APHIS facility, the building was designed and constructed on a build-to-suit basis to meet the tenant’s highly specialized operational needs. The facility comprises approximately 21,552 square feet on a 3.65-acre lot, and was completed in 2019. Strategically situated on the San Francisco Peninsula, the site offers exceptional access: just 11 minutes to San Francisco International Airport, about 42 minutes to Oakland International Airport, and within a convenient drive to the Port of San Francisco The property sits within one of the world’s premier biotech clusters, neighboring firms like Genentech, Verily Life Sciences, AbbVie, Life Technologies, and Amgen, creating high barriers to new industrial or lab development in the area.